Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect on quality of life of cisplatin added to single-agent chemotherapy as first-line treatment for elderly patients with advanced non-small cell lung cancer: Joint analysis of MILES-3 and MILES-4 randomised phase 3 trials.
Morabito A, Piccirillo MC, Maione P, Luciani A, Cavanna L, Bonanno L, Filipazzi V, Leo S, Cinieri S, Morgillo F, Burgio MA, Ferrara D, Rosetti F, Bianco R, Artioli F, Cortinovis D, Gebbia V, Fregoni V, Mencoboni M, Sandomenico C, Rossi A, Montanino A, Manzo A, Rocco G, Arenare L, Daniele G, Signoriello S, Gallo C, Perrone F, Gridelli C. Morabito A, et al. Among authors: montanino a. Lung Cancer. 2019 Jul;133:62-68. doi: 10.1016/j.lungcan.2019.05.009. Epub 2019 May 9. Lung Cancer. 2019. PMID: 31200830 Clinical Trial.
Gefitinib in non small cell lung cancer.
Costanzo R, Piccirillo MC, Sandomenico C, Carillio G, Montanino A, Daniele G, Giordano P, Bryce J, De Feo G, Di Maio M, Rocco G, Normanno N, Perrone F, Morabito A. Costanzo R, et al. Among authors: montanino a. J Biomed Biotechnol. 2011;2011:815269. doi: 10.1155/2011/815269. Epub 2011 May 23. J Biomed Biotechnol. 2011. PMID: 21660144 Free PMC article. Review.
Bevacizumab in non small cell lung cancer: development, current status and issues.
Sandomenico C, Costanzo R, Carillio G, Piccirillo MC, Montanino A, Di Maio M, Rocco G, Normanno N, Perrone F, Morabito A. Sandomenico C, et al. Among authors: montanino a. Curr Med Chem. 2012;19(7):961-71. doi: 10.2174/092986712799320673. Curr Med Chem. 2012. PMID: 22214464 Free article. Review.
Cetuximab in non-small-cell lung cancer.
Carillio G, Montanino A, Costanzo R, Sandomenico C, Piccirillo MC, Di Maio M, Daniele G, Giordano P, Bryce J, Normanno N, Rocco G, Perrone F, Morabito A. Carillio G, et al. Among authors: montanino a. Expert Rev Anticancer Ther. 2012 Feb;12(2):163-75. doi: 10.1586/era.11.178. Expert Rev Anticancer Ther. 2012. PMID: 22316364 Review.
Randomized phase III trial of gemcitabine and cisplatin vs. gemcitabine alone in patients with advanced non-small cell lung cancer and a performance status of 2: the CAPPA-2 study.
Morabito A, Gebbia V, Di Maio M, Cinieri S, Viganò MG, Bianco R, Barbera S, Cavanna L, De Marinis F, Montesarchio V, Costanzo R, Sandomenico C, Montanino A, Mancuso G, Russo P, Nacci A, Giordano P, Daniele G, Piccirillo MC, Rocco G, Gridelli C, Gallo C, Perrone F. Morabito A, et al. Among authors: montanino a. Lung Cancer. 2013 Jul;81(1):77-83. doi: 10.1016/j.lungcan.2013.04.008. Epub 2013 May 1. Lung Cancer. 2013. PMID: 23643177 Clinical Trial.
Advanced non-small-cell lung cancer with epidermal growth factor receptor mutations: current evidence and future perspectives.
Costanzo R, Montanino A, Di Maio M, Piccirillo MC, Sandomenico C, Giordano P, Daniele G, Franco R, Perrone F, Rocco G, Normanno N, Morabito A. Costanzo R, et al. Among authors: montanino a. Expert Rev Anticancer Ther. 2013 Oct;13(10):1207-18. doi: 10.1586/14737140.2013.845092. Expert Rev Anticancer Ther. 2013. PMID: 24134422 Review.
53 results